IRELYMI
AstraZeneca AB
Mark For: IRELYMI® trademark registration is intended to cover the category of
| Research |
OneLook
Acronym Finder
|
| Serial Number | 97348836 |
| Registration Number | 7110992 |
| Mark Literal Elements | IRELYMI |
| Mark Drawing Type | 4 - STANDARD CHARACTER MARK |
| Mark Type | TRADEMARK |
| Register | PRINCIPAL |
| Current Location | NEW APPLICATION PROCESSING 2022-04-09 |
| Basis | 1(b) 44(d) |
| Class Status | ACTIVE |
| Primary US Classes |
|
| Primary International Class |
|
| Filed Use | No |
| Current Use | No |
| Intent To Use | Yes |
| Filed ITU | Yes |
| 44D Filed | Yes |
| 44E Current | No |
| 66A Current | No |
| Current Basis | No |
| No Basis | No |
| Domestic Representative | Cara M. Kearney |
| Attorney Name | Cara M. Kearney |
| Attorney Docket Number | 104076/US |
Timeline
| 2022-04-06 | Application Filed |
| 2022-04-09 | Location: NEW APPLICATION PROCESSING |
| 2022-04-09 | Status: Live/Pending |
| 2022-04-09 | Status: New application will be assigned to an examining attorney approximately 6 months after filing date. |
| 2022-04-09 | Transaction Date |
Trademark Parties (Applicants & Owners)
| Party: |  AstraZeneca AB |
| Address | Astraallén Södertälje SWEDEN SE-15185 |
| Legal Entity Type | Corporation |
| Legal Entity State | SWEDEN |
Documents
 Application | 2022-04-06 | |
| Drawing | 2022-04-06 | |
| XSearch Search Summary | 2022-12-13 | |
| Non-Final Action | 2022-12-14 | |
| Response to Office Action | 2023-01-06 | |
| Amendment and Mail Process Complete | 2023-03-23 | |
| Amendment to Delete or Correct Basis | 2023-03-23 | |
| TRAM Snapshot of App at Pub for Oppostn | 2023-03-25 | |
| Notice of Publication | 2023-04-12 | |
| Notification Of Notice of Publication | 2023-04-12 | |
| OG Publication Confirmation | 2023-05-02 | |
| Notice of Registration-Notice | 2023-07-18 | |
| Registration Certificate | 2023-07-18 |
Attorney of Record
Good, Services, and Codes
IC 005. US 005 006 018 044 046 051 052. G & S: Pharmaceutical preparations and substances for the treatment of amyloidosis
| International Codes: | 5 |
| U.S. Codes: | 005,006,018,044,046,051,052 |
| Type Code | Type |
|---|---|
| GS0051 | Pharmaceutical preparations and substances |
| GS0051 | Pharmaceutical preparations and substances for the treatment of amyloidosis |
Trademark Filing History
| Description | Date | Proceeding Number |
|---|---|---|
| REGISTERED-PRINCIPAL REGISTER | 2023-07-18 | |
| NOTICE OF REGISTRATION CONFIRMATION EMAILED | 2023-07-18 | |
| PUBLISHED FOR OPPOSITION | 2023-05-02 | |
| OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | 2023-05-02 | |
| NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | 2023-04-12 | |
| APPROVED FOR PUB - PRINCIPAL REGISTER | 2023-03-24 | |
| TEAS/EMAIL CORRESPONDENCE ENTERED | 2023-03-22 | 96338 |
| CORRESPONDENCE RECEIVED IN LAW OFFICE | 2023-03-22 | 96338 |
| ASSIGNED TO LIE | 2023-03-22 | 96338 |
| TEAS RESPONSE TO OFFICE ACTION RECEIVED | 2023-01-06 | |
| NOTIFICATION OF NON-FINAL ACTION E-MAILED | 2022-12-14 | |
| NON-FINAL ACTION WRITTEN | 2022-12-14 | 96986 |
| NON-FINAL ACTION E-MAILED | 2022-12-14 | |
| ASSIGNED TO EXAMINER | 2022-12-12 | 96986 |
| NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | 2022-04-11 | |
| NEW APPLICATION ENTERED IN TRAM | 2022-04-09 | |
| NEW APPLICATION ENTERED | 2022-04-09 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.
| 